|1.||Soares, D G: 1 article (04/2015)|
|2.||Tjäderhane, L: 1 article (04/2015)|
|3.||Bianchi, L: 1 article (04/2015)|
|4.||Scheffel, D L: 1 article (04/2015)|
|5.||Hebling, J: 1 article (04/2015)|
|6.||Carrilho, M R O: 1 article (04/2015)|
|7.||Pashley, D H: 1 article (04/2015)|
|8.||Basso, F G: 1 article (04/2015)|
|9.||de Souza Costa, C A: 1 article (04/2015)|
|10.||Smajilagić, Amer: 1 article (02/2015)|
|1.||Bone Neoplasms (Bone Cancer)
09/01/2012 - "Our results highlight a selective and effective inhibitory activity of Alizarin towards cancerous cells, laying the basis for further studies to investigate its application in bone cancer therapy."
09/01/2012 - "In this study, we considered Alizarin, a natural hydroxyanthraquinone derived from madder root with high affinity to calcium and remarkable osteotropic features, as a novel approach for bone cancer treatment. "
09/01/2012 - "The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors."
05/01/2009 - "A very small amount of calcification was detected within the tumor using alizarin red staining. "
09/01/2012 - "Due to its antitumor properties, as demostrated in colon cancer cells, and to its tropism to bone, Alizarin may be an ideal drug to reduce bone tumor growth. "
08/01/2013 - "Perhaps, the Alizarin-DA-Fe(III) may be used as a new antitumor compound to induce peroxides in body to kill cancer cells."
07/14/2013 - "MTT assay tests of the V(V)O2L(A)L(B) and V(V)OL2 complexes against cancer cells have revealed that, when L is catechol, VOL2 showed broad-spectrum, high anticancer activities which were proportional to their concentration; however when L is naphthol or alizarin, VOL2 displayed little effect towards the cancer cells; moreover, complex 1 in the coordination model of V(V)O2L(A)L(B) showed specifically higher inhibition (88.65%) against HCT-8 than the clinical anticancer drug Fu-5 (69.97%). "
|4.||Wounds and Injuries (Trauma)
03/01/1994 - "Endothelial cell density (ECD) was assessed in the closed wound area after alizarin red staining. "
02/01/1999 - "Endothelial wound morphometry was performed after alizarin red and trypan blue staining. "
01/01/1999 - "Endothelial wound morphometry was performed after alizarin red and trypan blue staining, while stromal healing was assessed by counting polymorphonuclear leukocytes (PMNs) and keratocytes in the central and marginal wound areas. "
03/01/2011 - "Finally, human ASCs were treated in vitro with platelet-rich plasma to simulate an acute wound environment; proliferation and osteogenic differentiation were assessed (alkaline phosphatase, alizarin red, and quantitative reverse transcriptase polymerase chain reaction). "
09/01/2003 - "Necrosis (detected by alizarin red) and apoptosis (detected by active caspase-3) were present among the donor myoblasts following transplantation. "
04/01/2015 - "Eight replicates (n = 8) were prepared for each solutions for the following methods of analysis: violet crystal dye for cell adhesion (CA), quantification of total protein (TP), alizarin red for mineralization nodules formation (MN) and cell death by necrosis (flow cytometry); while twelve replicates (n = 12) were prepared for viable cell number (Trypan Blue) and cell viability (MTT assay). "
01/01/2002 - "Histomorphologic evaluation with von Kossa and alizarin-red stains and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) method were performed to evaluate cell calcifications, necrosis, and apoptosis. "
06/01/1992 - "Prevention of carbon tetrachloride-induced liver necrosis by the chelator alizarin sodium sulfonate."
|3.||ruberythric acid (AlP)
|1.||Transplantation (Transplant Recipients)
|3.||Phytotherapy (Herbal Therapy)